Konvomep is a Kit in the Human Prescription Drug category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is .
Product ID | 65628-272_688ed6f1-d78a-4006-a682-57021cb38a3e |
NDC | 65628-272 |
Product Type | Human Prescription Drug |
Proprietary Name | Konvomep |
Generic Name | Omeprazole And Sodium Bicarbonate |
Dosage Form | Kit |
Marketing Start Date | 2023-01-01 |
Marketing Category | NDA / |
Application Number | NDA213593 |
Labeler Name | Azurity Pharmaceuticals, Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2023-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
13107-115 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
13107-116 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
13107-117 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
16714-508 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
16714-509 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
27241-029 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
27241-030 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
27241-031 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
27241-032 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
50228-363 | Omeprazole and Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
42291-585 | Omeprazole/Bicarbonate | Omeprazole and Sodium Bicarbonate |
49884-268 | Omeprazole/Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
49884-269 | Omeprazole/Sodium Bicarbonate | Omeprazole and Sodium Bicarbonate |
11523-7265 | Zegerid OTC | Omeprazole and Sodium Bicarbonate |
11523-7276 | Zegerid OTC | omeprazole and sodium bicarbonate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KONVOMEP 90231566 not registered Live/Pending |
Azurity Pharmaceuticals, Inc. 2020-10-02 |